Article and Video CATEGORIES

Cancer Journey

Search By

Ladies Home Journal Featured Article
Author
Dr. Pinder

I would like to share with all of you an article on one of my patients that was featured in the November 2012 issue of Ladies Home Journal.  

I think her story will resonate with all of you. My patient, Wesley Fay, epitomizes the well-informed, passionate, caring type of person that I encounter so often on GRACE. Though she is a private person, she was willing to share her story in hopes of inspiring others and raising awareness about lung cancer. I’d also like to express my thanks to the team at Ladies Home Journal. Everyone we encountered was interested in helping us tell Wesley’s story and showed such compassion and sensitivity. Wesley’s story has definitely touched a lot of people and I can’t think of a group who would appreciate her insights more than the GRACE community.

You can find the full article at http://lhj.com/health/conditions/cancer/what-its-like-having-lung-cancer/.

Mary Pinder-Schenck, M.D.

 

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on